DOTmed August 17, 2022
John R. Fischer

Intelerad Medical Systems has acquired PenRad Technologies, a software manufacturer for breast and lung screening programs.

Based in Buffalo, Minnesota, PenRad has three core products that are designed to reduce overhead costs, decrease liability risk and increase patient satisfaction. They include its mammography reporting workflow solution, PenRad; a lung screening and tracking software, PenLung; and PenTrac, for standardizing mammography, patient tracking and MQSA (Mammography Quality Standards Act) reporting.

The addition of these technologies will expand Intelerad’s offerings in breast imaging and lung analytics, as well as optimize workflow for radiologists, according to Mike Lipps, CEO of Intelerad. “By integrating PenRad’s core solutions into our company, we can ensure all patients have access to the scans they need to decrease health...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Health IT, Mergers & Acquisitions / JV, Technology, Trends
Cutting and pasting (aka cloned) EHR portions can lead to false claims
Roundtable: How can APIs drive effectiveness and interoperability in the NHS?
Oracle plans to move headquarters to healthcare hub Nashville
Back to Basics: The Role of AI in Cybersecurity
InnovationRx: Chelsea Clinton Invests In 24/7 Pediatrics Startup

Share This Article